Editorial
Published on 15 Aug 2022
Editorial: Leveraging pharmacovigilance data mining with “the patient” in mind
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.980645
- 2,510 views
30 articles related to "Pharmacovigilance Data"
Articles
Original Research
Published on 15 Apr 2022
Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.739044
- 10,258 views
- 30 citations
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 4,254 views
- 8 citations
Original Research
Published on 24 Apr 2026
Real world pharmacovigilance assessment of drug related perinatal depression risks
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1820606
- 430 views
Review
Published on 11 Apr 2016
Patient Participation and the Use of Ehealth Tools for Pharmacoviligance
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2016.00090
- 8,607 views
- 24 citations
Perspective
Published on 16 Aug 2021
Increase of Adverse Events After Intravenous Injection of Gentamicin in Horses Between 2015 and 2017—From Marketing Authorization Holder's Point of View
in Veterinary Pharmacology and Toxicology
Frontiers in Veterinary Science
doi 10.3389/fvets.2021.710571
- 13,160 views
- 4 citations
Review
Published on 02 Jul 2019
Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering
in Autoimmune and Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2019.01389
- 46,168 views
- 119 citations
Original Research
Published on 30 Apr 2024
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1396752
- 11,535 views
- 9 citations
Perspective
Published on 25 Mar 2026
Closing the loop: human-augmented, mechanistically enhanced AI for proactive management of drug–drug interactions
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1767646
- 728 views
Review
Published on 09 Jul 2014
Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2014.00162
- 27,386 views
- 57 citations
Original Research
Published on 18 Mar 2024
Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376535
- 11,052 views
- 13 citations
Original Research
Published on 13 Dec 2022
Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1032199
- 17,155 views
- 33 citations
Original Research
Published on 24 Nov 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.797852
- 7,162 views
- 9 citations
Original Research
Published on 23 Feb 2024
Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1335309
- 4,122 views
- 7 citations
Original Research
Published on 29 Oct 2024
Region-independent active CNS net uptake of marketed H+/OC antiporter system substrates
in Non-Neuronal Cells
Frontiers in Cellular Neuroscience
doi 10.3389/fncel.2024.1493644
- 3,484 views
- 1 citation
Original Research
Published on 20 Jan 2026
Unveiling the hidden cardiovascular risk of sipuleucel-T: a pharmacovigilance analysis using the FDA Adverse Event Reporting System, 2010–2025
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1716090
- 1,364 views